241. THE – December 14, 1998 SEASON OF SHARING When It’s Hard to Stay Afloat Foster City couple labors with life She starts with the big turquoise ones. Every morning, and again every evening, Pam Alvarado works her way through the handful of pills, from biggest to smallest. Next up are the pale green-and-white capsules, then the pink tablets and the white lozenges. They go down easier in this order. When you take 20 pills a day, you have to have a system. Alvarado, 52, is feeling poorly. In fact, everyone in this household in a Foster City seniors’ residence is ….. (FL) – October 25, 1998 THREE ILLNESSES CAN CRIPPLE LUNGS Dear Dr. Donohue: I have had bronchitis for seven months. Will you explain the difference between bronchitis, emphysema and asthma? I’m so sick of using inhalers. Is there anything else? I blame my troubles on El Nino. What do you think? – E. M. Dear E. M. : Chronic bronchitis is a cough that lingers for at least three months in two consecutive years. Along with the cough, chronic bronchitis produces copious amounts of thick, sticky mucus. “Chronic” is ….. – October 25, 1998 EMPHYSEMA, ASTHMA AFFECT BREATHING Dear Dr. Donohue: I have had bronchitis for seven months. Will you explain the difference between bronchitis, emphysema and asthma? I’m so sick of using inhalers. Is there anything else? I blame my troubles on El Nino. What do you think? Chronic bronchitis is a cough that lingers for at least three months in two consecutive years. Along with the cough, chronic bronchitis produces copious amounts of thick, sticky mucus. “Chronic” is used to distinguish ….. Rocky Mountain News (CO) – April 26, 1998 ALLERGIES TAKE A BREATHER DESIGNER ANTIBODIES MAY BRING THE SPRING SNEEZE TO ITS KNEES As anyone with a nose knows, this spring’s pollen crop has arrived early and often across much of the country, courtesy of the mild, wet El Nino winter. Spores from trees, followed by grasses, followed by weeds, with a bonus dollop of molds, are expected to be seizing the sinuses and clogging up the bronchial tubes from now until the fall frosts. An estimated 35 million Americans suffer from allergic rhinitis or hay fever and about 15 million have asthma, with much overlap …. 245. Times, The (London, England) – April 7, 1993 Drug shares stay under the weather, Stock Market GOOD news is a rare commodity these days in the pharmaceutical sector, which has suffered more than its fair share of setbacks in the past six months. Regarded as a safe haven for investors during times of economic hardship, pharmaceutical companies are emerging from the recession looking positively shell-shocked. These days they appear friendless on both sides of the Atlantic and their prospects remain gloomy. The pharmaceutical industry was dealt a blow with the election of President …. 246. (FL) – May 5, 2007 How Should Pregnant Women Deal With Asthma? , By DENNIS LEDFORD, M. D. Tribune correspondent Asthma is one of the most common chronic conditions affecting pregnancy. Approximately 4 percent to 8 percent of pregnant women suffer from asthma. Women whose asthma is well controlled throughout pregnancy have an excellent chance for a normal pregnancy and a healthy baby. However, severe or poorly treated asthma is associated with premature birth, increased need for Caesarean sections, elevated blood pressure for the mother and growth retardation for the ….. Times Union, The (Albany, NY) – December 4, 1998 DRUG MANUFACTURER ISSUES WARNING ABOUT MEDICATION WASHINGTON — Doctors should carefully watch asthma patients who take the drug Singulair for signs of a rare but serious complication called Churg-Strauss syndrome, manufacturer Merck & Co. warned Thursday. Churg-Strauss syndrome is a tissue disorder that sometimes strikes adult asthma patients and, if untreated, can destroy organs. Merck said Thursday that it has received fewer than 20 reports of Singulair patients developing symptoms of Churg-Strauss, out of 600, 000 ….. Birmingham Post, The (England) – August 7, 1998 The Birmingham Post: Business: Shares slide as Zeneca disappoints at half time Shares in Zeneca dropped sharply yesterday after the drugs giant revealed a big fall in half-time profits. The company, a persistent subject of takeover rumours in the City, said the strong pound had taken GBP81 million off the bottom line, and was likely to cost it about GBP110 million in full-year profits. Pre-tax profits for the first six months of the year came in at GBP626 million, lower than analysts had been forecasting and down from GBP669 million a year ago. The lower figure ….. Observer, The (London, England) – May 17, 1998 The Observer: Money: Zeneca coming on a treat: Stockwatch: Investment KEEP an eye on Zeneca. The shares, at 2511p, were given a fillip on Friday when data in the Lancet showed that Nolvadex, its anti-cancer treatment, cuts the risk of recurrence of breast cancer after surgery. Nolvadex comes off patent in the US in 2002, but it may be cleared for preventative treatment, which could cushion future sales by up to pounds 150 million a year. Zeneca’s current best-seller is heart-failure treatment Zestril, with pounds 632m of sales last year. It ….. Times, The (London, England) – March 12, 1997 Cupboard far from bare, Tempus THE giddy rise of Zeneca’s share price is enough to give investors altitude sickness. Less than two years ago, the price soared through the Pounds 10 barrier in a fever of takeover speculation, and sceptics warned the market that it could never last. Yesterday, shares in the drugs company leapt to Pounds 19. 38, before falling back to end a hectic day 42p lower at Pounds 18. 60 1/2. Zeneca is now valued at about Pounds 18 billion. Sir David Barnes, Zeneca’s chief …. |